[BRIDGE registry (safety and efficacy registry Bx Cyper stent in the RevascularIzation of patients with siGnificative risk of rEstenosis): protocol description and preliminary results]

Ann Cardiol Angeiol (Paris). 2004 May:53 Suppl 1:29s-31s. doi: 10.1016/s0003-3928(04)90006-6.
[Article in French]
No abstract available

MeSH terms

  • Clinical Protocols
  • Combined Modality Therapy
  • Coronary Restenosis / complications
  • Coronary Restenosis / prevention & control*
  • Coronary Stenosis / complications
  • Coronary Stenosis / therapy
  • Diabetes Complications / prevention & control*
  • Diabetes Complications / therapy
  • Diabetes Mellitus, Type 2 / complications*
  • Drug Delivery Systems*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Registries*
  • Risk Factors
  • Sirolimus / administration & dosage*
  • Stents*

Substances

  • Immunosuppressive Agents
  • Sirolimus